ROCKET PHARMACEUTICALS, INC.

By person

24 insiders · 142 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

RTW INVESTMENTS, LP entity

Director

$48.50M (4)

$29.02M (1)

+$19.48M

49,833,695

45.40%

$169.58M

+1.7%

Makker Gotham

Director

—

$10.20M (6)

−$10.20M

1,711,747

1.56%

$5.83M

−34.9%

SOUTHWELL DAVID P

Director

$105.00K (1)

$3.41M (6) scheduled

−$3.30M

317,646

0.2894%

$1.08M

+145.3%

Shah Gaurav

CEO

$483.11K (2)

$3.33M (21)

−$2.85M

1,462,832

1.33%

$4.98M

+65.0%

Patel Kinnari

See Remarks

$193.68K (3)

$1.52M (11)

−$1.33M

665,240

0.6060%

$2.26M

+129.4%

Schwartz Jonathan David

See Remarks

—

$1.09M (13)

−$1.09M

299,064

0.2724%

$1.02M

—

Militello John

See Remarks

—

$906.52K (33)

−$906.52K

89,780

0.0818%

$305.52K

+1,970%

Wilson Martin

General Counsel

—

$705.82K (19)

−$705.82K

598,489

0.5452%

$2.04M

+2,981%

White Mark Andrew

See Remarks

—

$421.68K (3)

−$421.68K

69,140

0.0630%

$235.28K

+345,600%

Stevens Christopher James

Chief Operating Officer

—

$128.27K (1)

−$128.27K

505,784

0.4607%

$1.72M

—

Chaudhuri Sarbani

See Remarks

—

$84.19K (2)

−$84.19K

262,809

0.2394%

$894.34K

+65.0%

Bjork Elisabeth

Director

$68.50K (2)

—

+$68.50K

50,000

0.0455%

$170.15K

—

Ondrey Aaron

Chief Financial Officer

—

$43.90K (2)

−$43.90K

128,173

0.1168%

$436.17K

—

Yalamanchi Naveen

Director

—

$14.01K (1)

−$14.01K

113,641

0.1035%

$386.72K

−0.6%

WONG RODERICK

Director

—

32,855,453

29.93%

$111.81M

+6.3%

Rizvi Syed Ali-aamir

Chief Medical Officer

—

407,874

0.3716%

$1.39M

—

Fong Peter

Director

—

76,195

0.0694%

$259.29K

—

Dolsten Mikael

Director

—

67,082

0.0611%

$228.28K

—

GRANADILLO PEDRO P

Director

—

54,734

0.0499%

$186.26K

—

Malik Fady Ibraham

Director

—

52,862

0.0482%

$179.89K

—

BOESS CARSTEN

Director

—

52,862

0.0482%

$179.89K

—

Pratumsuwan Piratip

Director

—

30,000

0.0273%

$102.09K

—

RITTER DALE

Vice President, Finance

—

19,827

0.0181%

$67.47K

+170.6%

DEVON PARK BIOVENTURES LP entity

10% owner

—

0.0000%

$0.00

−100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Shah Gaurav

21 May 2026

CEO

Sold after exercise

55,684

$3.09

$171.84K

SOUTHWELL DAVID P

15 Apr 2024

Director

Sold after exercise

10,000

$24.05

$240.52K

SOUTHWELL DAVID P

12 Apr 2024

Director

Sold after exercise

10,284

$25.16

$258.70K

SOUTHWELL DAVID P

12 Apr 2024

Director

Sold after exercise

59,716

$24.22

$1.45M

Militello John

29 Feb 2024

See Remarks

Sold after exercise

10,000

$29.85

$298.45K

Show all 142 transactions →

ROCKET PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out